Ted Mathias Image

Ted Mathias

Partner

Axinn, Veltrop & Harkrider

Ted Mathias is a partner at Axinn, Veltrop & Harkrider LLP. Ted’s practice focuses on trying patent cases. In the last several years, he has tried three cases to judgment and served as lead counsel in multiple cases involving 15+ patents. Ted has litigated patent cases and handled successful appeals to the Federal Circuit in the areas of medical devices, pharmaceuticals, mechanical devices, e-commerce and software. Clients frequently turn to him for guidance on patent remedies and competition issues that arise in connection with patent disputes.

Recent Articles by Ted Mathias

The CRISPR Tug of War

The University of California (“UC”) and The Broad Institute, Inc. (“Broad”) are among the leaders in the development of CRISPR technology.  Both UC and Broad filed patent applications for claims broadly drawn to CRISPR-Cas9 systems and methods of DNA editing.  These parties are currently engaged in litigation over patents concerning the potentially most lucrative application of CRISPR technology – the use of CRISPR-Cas9 in plant and animal (eukaryotic) cells.  The outcome of this litigation will affect control of the CRISPR platform and development of the technology.